These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13431634)

  • 21. [Behavior of the clinical and serum protein picture in tuberculous patients treated with a heavy metal derivative of isoniazid].
    MASSA B; MANZONE P; SARTORIO E
    Gazz Med Ital; 1958 Oct; 117(10):436-9. PubMed ID: 13609867
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT
    Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
    De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.
    Baldan HM; De Rosa HJ; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Nov; 28(8):409-13. PubMed ID: 17828712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the types of chemotherapy in tuberculosis. I. The preceding INH treatment, followed by streptomycin-PAS therapy to relatively early cavities].
    FUJIOKA K; YOSHIDA F; SUGIURA A; KAI Y; KASAI T; NISHIYAMA K; HIRASHIMA N; YOSHIDA N; SHIMODA T
    Kekkaku; 1957 Feb; 32(2):93-7. PubMed ID: 13417317
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
    Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
    Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of serum level determinations for INH].
    de Graaff JL
    Ned Tijdschr Geneeskd; 1967 Nov; 111(46):2105-7. PubMed ID: 6064782
    [No Abstract]   [Full Text] [Related]  

  • 30. When we give prophylactic INH.
    Gongaware T
    Med Times; 1976 Jul; 104(7):59. PubMed ID: 933770
    [No Abstract]   [Full Text] [Related]  

  • 31. [TREATMENT OF PULMONARY TUBERCULOSIS WITH LARGE DOSES OF INH].
    DELOFF L; GRZESKOWSKI J; MICHALIK M; OKLEK K
    Gruzlica (1926); 1963 Mar; 31():201-6. PubMed ID: 14060343
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
    Machado A; Finkmoore B; Emodi K; Takenami I; Barbosa T; Tavares M; Reis MG; Arruda S; Riley LW
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):719-25. PubMed ID: 19460247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [RESULTS OF THE TREATMENT OF RECENT PULMONARY TUBERCULOSIS WITH LARGE DOSES OF INH].
    KOCHNOWSKI G
    Gruzlica (1926); 1963 Mar; 31():263-6. PubMed ID: 14060351
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of caseo-cavernous tuberculosis in children with large doses of INH and small doses of PAS].
    STOJKOV N
    Tuberkuloza; 1962; 14():123-31. PubMed ID: 13984298
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid].
    Cui ZL; Jing FX; Hu ZY; Wu ZR; Zhao JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):439-41. PubMed ID: 15312553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.